EUVIMEDEUVIMED entdecken
Crossref

Targeting Sphingosine-1-Phosphate Signaling to Prevent the Progression of Aortic Valve Disease

Marcel Benkhoff iD, Maike Barcik, Philipp Mourikis iD, Jana Dahlmanns, Paulina Kahmann, Philipp Wollnitzke, Moritz Hering, Tim Huckenbeck, Julia Hoppe, Nina Semleit, Jennifer Deister-Jonas, Saif Zako und 23 weitere

Circulation · 28.01.2025 · 151 (4) · 333-347

DOI: 10.1161/circulationaha.123.067270 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 28.01.2025. Verfasst von Marcel Benkhoff und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Pulmonology, and Vascular Medicine, University Hospital Düsseldorf, Medical Faculty of the Heinrich Heine University Düssel…. Hauptthemen laut MEDLINE: Sphingosine, Lysophospholipids, Signal Transduction, Aortic Valve. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Aortic valve disease (AVD) is associated with high mortality and morbidity. To date, there is no pharmacological therapy available to prevent AVD progression. Because valve calcification is the hallmark of AVD and S1P (sphingosine-1-phosphate) plays an important role in osteogenic signaling, we examined the role of S1P signaling in aortic stenosis disease. METHODS: AVD progression and its consequences for cardiac function were examined in a murine wire injury–induced AVD model with and without pharmacological and genetic modulation of S1P production, degradation, and receptor signaling. S1P was measured by liquid chromatography-mass spectrometry. Calcification of human valvular interstitial cells and their response to biomechanical stress were analyzed in the context of S1P signaling. Human explanted aortic valves from patients undergoing aortic valve replacement and cardiovascular magnetic resonance imaging were analyzed for S1P by liquid chromatography-mass spectrometry. RESULTS: Raising S1P concentrations in mice with injury-induced AVD by pharmacological inhibition of its sole degrading enzyme S1P lyase vastly enhanced AVD progression and impaired cardiac function resembling human disease. In contrast, low S1P levels caused by SphK1 (sphingosine kinase 1) deficiency potently attenuated AVD progression. We found S1P/S1PR2 (S1P receptor 2) signaling to be responsible for the adverse S1P effect because S1PR2-deficient mice were protected against AVD progression and its deterioration by high S1P. It is important to note that pharmacological S1PR2 inhibition administered after wire injury successfully prevented AVD development. Mechanistically, biomechanical stretch stimulated S1P production by SphK1 in human valvular interstitial cells as measured by C17-S1P generation, whereas S1P/S1PR2 signaling induced their osteoblastic differentiation and calcification through osteogenic RUNX2/OPG signaling and the GSK3β-Wnt-β-catenin pathway. In patients with AVD, stenotic valves exposed to high wall shear stress had higher S1P content and increased SphK1 expression. CONCLUSIONS: Increased systemic or local S1P levels lead to increased valvular calcification. S1PR2 antagonists and SphK1 inhibitors may offer feasible pharmacological approaches to human AVD in prophylactic, disease-modifying or relapse-preventing manners.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SphingosineLysophospholipidsSignal TransductionAortic ValveAortic Valve StenosisAortic Valve DiseaseAnimalsHumansMiceDisease ProgressionMaleMice, Inbred C57BLDisease Models, AnimalCalcinosisPhosphotransferases (Alcohol Group Acceptor)Sphingosine-1-Phosphate ReceptorsAldehyde-LyasesMice, KnockoutReceptors, LysosphingolipidFemale

Stichwörter der Autor:innen

aortic valve diseasecalcificationsphingosine-1-phosphate

Substanzen

Sphingosinesphingosine 1-phosphateLysophospholipidsPhosphotransferases (Alcohol Group Acceptor)Sphingosine-1-Phosphate ReceptorsAldehyde-LyasesReceptors, Lysosphingolipid

Autor:innen und Institutionen

  • Department of Cardiology, Pulmonology, and Vascular Medicine, University Hospital Düsseldorf, Medical Faculty of the Heinrich Heine University Düsseldorf, Düsseldorf, Germany (M. Benkhoff, M. Barcik, P.M., J.D., P.K., M…
  • Institute of Analytical Chemistry, University of Vienna, Vienna, Austria (M. Benkhoff, C.C., R.A.).
  • Institute of Molecular Medicine III, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany (P.W., J.H., N.S., J.D.-J., B.L.).
  • Department of Cardiac Surgery, University Hospital Aachen, RWTH Aachen University, Germany (M. Barth, P.A.).
  • Department of Molecular Cardiology, Heinrich Heine University Düsseldorf, Germany (J.H.).
  • Department of Cardiac Surgery, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (A.L.).

ORCID-Profile: Marcel Benkhoff, Philipp Mourikis, Carolin Helten, Amin Polzin

Zitieren

APA

Benkhoff, M., Barcik, M., Mourikis, P., Dahlmanns, J., Kahmann, P., Wollnitzke, P., Hering, M., Huckenbeck, T., Hoppe, J., Semleit, N., Deister-Jonas, J., Zako, S., Seel, J., Coman, C., Barth, M., Cramer, M., Helten, C., Wildeis, L., Hu, H., …, & Polzin, A. (2025). Targeting Sphingosine-1-Phosphate Signaling to Prevent the Progression of Aortic Valve Disease. Circulation, 151(4), 333-347. https://doi.org/10.1161/circulationaha.123.067270

Vancouver

Benkhoff M, Barcik M, Mourikis P, Dahlmanns J, Kahmann P, Wollnitzke P, et al. Targeting Sphingosine-1-Phosphate Signaling to Prevent the Progression of Aortic Valve Disease. Circulation. 2025;151(4):333-347. doi:10.1161/circulationaha.123.067270

BibTeX
@article{Benkhoff2025,
  author = {Benkhoff, Marcel and Barcik, Maike and Mourikis, Philipp and Dahlmanns, Jana and Kahmann, Paulina and Wollnitzke, Philipp and Hering, Moritz and Huckenbeck, Tim and Hoppe, Julia and Semleit, Nina and Deister-Jonas, Jennifer and Zako, Saif and Seel, Jasmin and Coman, Cristina and Barth, Mareike and Cramer, Mareike and Helten, Carolin and Wildeis, Laura and Hu, Hao and Al-Kassis, Gabrielle and Metzen, Daniel and Hesse, Julia and Weber, Jessica and Dannenberg, Lisa and Akhyari, Payam and Lichtenberg, Artur and Quast, Christine and Gerdes, Norbert and Zeus, Tobias and Borst, Oliver and Kelm, Malte and Petzold, Tobias and Ahrends, Robert and Levkau, Bodo and Polzin, Amin},
  title = {Targeting Sphingosine-1-Phosphate Signaling to Prevent the Progression of Aortic Valve Disease},
  journal = {Circulation},
  year = {2025},
  volume = {151},
  number = {4},
  pages = {333--347},
  doi = {10.1161/circulationaha.123.067270}
}
Kostenlos starten →